Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
Sulfa	O
(Sulfonamide	O
Antibiotics)	O
/	O
Tetracycline	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Abdominal	O
pain	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
Mr	O
___	O
is	O
a	O
___	O
yr	O
old	O
male	O
with	O
hx	O
of	O
COPD,	O
DM,	O
HTN,	O
HLD,	O
remote	O
sz,	B-Seizures
and	O
recent	O
L	O
___	O
toe	O
amputation	O
for	O
osteomyelitis.	O
He	O
is	O
also	O
undergoing	O
gammaknife	O
treatment	O
here	O
for	O
HCC	O
now	O
likely	O
metastatic	O
to	O
lungs.	O
The	O
patient	O
was	O
admitted	O
to	O
___	O
___	O
after	O
he	O
developed	O
acute	O
worsening	O
of	O
R	O
sided	O
pain.	O
States	O
that	O
he	O
woke	O
up	O
with	O
it,	O
tried	O
taking	O
percocet	O
left	O
over	O
from	O
his	O
toe	O
surgery	O
but	O
no	O
relief,	O
has	O
had	O
some	O
pain	O
here	O
but	O
no	O
this	O
severe.	O
Describes	O
as	O
knife	O
stabbing,	O
constant,	O
not	O
relieved	O
with	O
BM.	O
Was	O
doubled	O
over.	O
Not	O
worse	O
with	O
eating,	O
no	O
flank	O
pain.	O
no	O
dysuria,	O
hematuria,	O
no	O
hx	O
kidney	O
stones.	O
But	O
he	O
was	O
most	O
concerned	O
about	O
kidney	O
stone.	O
Did	O
get	O
rear	O
ended	O
by	O
truck	O
at	O
about	O
25mph	O
___	O
weeks	O
ago,	O
states	O
he	O
had	O
some	O
whiplash	O
with	O
back	O
strain	O
but	O
no	O
ab	O
pain	O
at	O
that	O
time.	O
In	O
___	O
he	O
had	O
ab	O
CT	O
performed	O
that	O
showed	O
increase	O
in	O
liver	O
lesions	O
as	O
well	O
as	O
R	O
lung	O
base	O
infiltrate.	O
he	O
was	O
started	O
on	O
unasyn	O
for	O
possible	O
RLL	O
pneumonia	B-Lower_respiratory_tract_infection
however	O
on	O
review	O
of	O
scans	O
by	O
his	O
PCP	O
who	O
is	O
pulmonologist	O
abx	O
were	O
stopped.	O
He	O
was	O
started	O
on	O
oxycodone	O
and	O
morphine	O
but	O
states	O
he	O
did	O
not	O
get	O
relief.	O
He	O
was	O
transferred	O
to	O
___	O
for	O
possible	O
further	O
radiation	O
for	O
pain	O
control.	O
Currently	O
still	O
very	O
painful,	O
points	O
to	O
R	O
subcostal	O
region,	O
no	O
radiation	O
of	O
pain,	O
not	O
tender	O
over	O
ribs.	O
He	O
has	O
nausea	O
for	O
several	O
weeks	O
that	O
is	O
worse	O
latety,	O
no	O
vomiting,	O
poor	O
appetite.	O
Denies	O
any	O
new	O
cough,	O
sputum,	O
SOB.	O
Has	O
chronic	O
lung	O
disease,	O
after	O
talking	O
to	O
his	O
pulmonologist	O
on	O
phone	O
his	O
respiratory	O
symptoms	O
lately	O
are	O
improved	O
on	O
xolair.	O
Past	O
Medical	O
History:	O
PAST	O
ONCOLOGIC	O
HISTORY:	O
Mr.	O
___	O
is	O
a	O
___	O
male	O
who	O
was	O
incidentally	O
found	O
to	O
have	O
a	O
liver	O
mass	O
during	O
an	O
admission	O
to	O
___	O
for	O
asthma,	O
pneumonia,	B-Lower_respiratory_tract_infection
and	O
bronchiectasis.	O
He	O
underwent	O
a	O
biopsy	O
on	O
___	O
at	O
___	O
which	O
showed	O
fragmented	O
atypical	O
hepatocellular	O
neoplasm	O
with	O
absence	O
in	O
portal	O
areas,	O
increase	O
nuclear	O
density,	O
minimally	O
increased	O
nuclear-cytoplasmic	O
ratio	O
and	O
mild	O
atypicality.	O
Immunohistochemical	O
stains	O
of	O
the	O
tumor	O
diffusely	O
positive	O
for	O
Hep	O
Par	O
1,	O
cytokeratins	O
AE1,	O
AE3,	O
and	O
CAM5.2,	O
and	O
focally	O
positive	O
for	O
glypican.	O
The	O
differential	O
includes	O
hepatic	O
adenoma	O
with	O
fatty	O
change	O
and	O
possible	O
early	O
evolving	O
hepatocellular	O
carcinoma.	O
The	O
patient	O
was	O
referred	O
to	O
Dr.	O
___	O
for	O
further	O
evaluation.	O
CT	O
abdomen	O
___	O
showed	O
a	O
4.8	O
cm	O
mass	O
in	O
segment	O
___	O
of	O
the	O
liver	O
concerning	O
for	O
hepatocellular	O
carcinoma	O
although	O
not	O
typical.	O
The	O
patient	O
was	O
reviewed	O
in	O
liver	O
tumor	O
conference	O
and	O
the	O
atypical	O
features	O
on	O
imaging	O
and	O
pathology	O
were	O
noted.	O
The	O
patient	O
underwent	O
confirmatory	O
biopsy	O
at	O
___,	O
___,	O
which	O
demonstrated	O
a	O
well	O
differentiated	O
hepatocellular	O
carcinoma	O
rising	O
in	O
the	O
background	O
of	O
a	O
dysplastic	O
nodule.	O
As	O
pulmonary	O
comorbidities	O
and	O
large	O
size	O
precluded	O
other	O
treatment	O
options,	O
underwent	O
cyberknife	O
___	O
to	O
segmen	O
IV	O
lesion.	O
___	O
imaging	O
stable/decreased	O
size	O
of	O
treatment	O
segmen	O
IV	O
lesion	O
but	O
new	O
segement	O
5	O
lesion	O
for	O
which	O
he	O
completed	O
another	O
gammaknife	O
on	O
___.	O
A	O
CT	O
scan	O
___	O
with	O
contrast	O
liver	O
protocol,	O
unfortunately,	O
showed	O
further	O
area	O
of	O
enhancement	O
adjacent	O
to	O
the	O
origin	O
of	O
this	O
area	O
and	O
he	O
was	O
not	O
thought	O
to	O
be	O
suitable	O
candidate	O
for	O
other	O
liver	O
directed	O
therapies,	O
thus	O
stereotactic	O
body	O
radiotherapy	O
was	O
again	O
completed	O
___.	O
!/___	O
a	O
new	O
enhancing	O
lesion	O
in	O
4A	O
was	O
suspicious	O
and	O
at	O
that	O
time	O
also	O
developing	O
micronodular	O
areas,	O
completed	O
further	O
gammaknife	O
___.	O
PAST	O
MEDICAL	O
HISTORY:	O
___	O
as	O
above	O
L	O
toe	O
osteiomyelitis	O
s/p	O
amputation	O
Hx	O
Enterococcus	O
UTI	B-Urinary_tract_infection
-	O
during	O
hospitalization	O
for	O
toe	O
surgery,	O
completed	O
course	O
of	O
unasyn	O
1.	O
Per	O
last	O
hepatology	O
note:	O
With	O
regards	O
to	O
his	O
cirrhosis,	O
he	O
has	O
never	O
had	O
overt	O
hepatic	O
decompensation	O
other	O
than	O
his	O
hepatocellular	O
carcinoma.	O
He	O
has	O
never	O
had	O
ascites,	O
confusion	O
or	O
GI	O
bleeding.	O
He	O
has	O
not	O
had	O
an	O
upper	O
endoscopy	O
as	O
it	O
has	O
been	O
deferred	O
due	O
to	O
his	O
other	O
comorbid	O
illnesses.	O
He	O
has	O
exposure	O
and	O
immunity	O
to	O
hepatitis	O
B	O
and	O
he	O
has	O
never	O
had	O
an	O
elevated	O
AFP	O
as	O
part	O
of	O
his	O
hepatocellular	O
carcinoma.	O
2.	O
Status	O
post	O
knee	O
replacement	O
x3.	O
3.	O
Hypertension.	O
4.	O
Diabetes.	O
adult	O
onset.	O
not	O
on	O
medication.	O
5.	O
Bronchiectasis.	O
6.	O
COPD	O
7.	O
Lichen	O
planus.	O
8.	O
Status	O
post	O
eye	O
surgery.	O
9.	O
Reported	O
history	O
of	O
a	O
seizure	B-Seizures
disorder	O
characterized	O
by	O
two	O
syncopal	O
episodes	O
as	O
well	O
as	O
self	O
reported	O
positive	O
EEG.	O
The	O
patient	O
has	O
been	O
maintained	O
on	O
Tegretol.	O
10.	O
s/p	O
b/l	O
cataract	O
surgery	O
Social	O
History:	O
___	O
Family	O
History:	O
FAMILY	O
HISTORY:	O
Father	O
died	O
of	O
heart	O
disease	O
age	O
___,	O
Mother	O
died	O
of	O
colitis	O
age	O
___	O
Physical	O
Exam:	O
General:	O
NAD	O
VITAL	O
SIGNS:	O
97.8	O
138/60	O
72	O
18	O
92%RA	O
and	O
with	O
walking	O
HEENT:	O
MMM,	O
no	O
OP	O
lesions	O
Neck:	O
supple,	O
no	O
JVD	O
Lymph:	O
no	O
cervical,	O
supraclavicular,	O
axillary	O
or	O
inguinal	O
adenopathy,	O
mildly	O
tender	O
R	O
cervical	O
LN	O
but	O
rubbery	O
not	O
prominent	O
or	O
firm	O
CV:	O
RR,	O
NL	O
S1S2	O
no	O
S3S4	O
or	O
MRG	O
PULM:	O
occasional	O
exp	O
wheeze,	O
faint	O
R	O
base	O
crackles,	O
o/w	O
CTAB	O
ABD:	O
BS+,	O
soft,	O
NTND,	O
+hepatomegaly	O
w/	O
tender	O
lower	O
border,	O
no	O
rebound	O
or	O
guarding	O
EXT:	O
warm	O
well	O
perfused,	O
no	O
edema	O
SKIN:	O
No	O
rashes	O
or	O
skin	O
breakdown,	O
R	O
___	O
toe	O
amputation	O
healed	O
well	O
stub	O
slightly	O
erythematous	O
per	O
pt	O
significantly	O
improved,	O
no	O
drainage	O
NEURO:	O
alert	O
and	O
oriented	O
x	O
4,	O
___,	O
EOMI,	O
no	O
nystagmus,	O
face	O
symmetric,	O
no	O
tongue	O
deviation,	O
full	O
hand	O
grip,	O
shoulder	O
shrug	O
and	O
bicep	O
flexion,	O
full	O
toe	O
dorsiflexion	O
and	O
hip	O
flexion	O
against	O
resistance	O
bilateral,	O
sensation	O
intact	O
to	O
light	O
touch,	O
no	O
clonus	O
Pertinent	O
Results:	O
DAY	O
OF	O
DISCHARGE	O
LABS:	O
138	O
100	O
10	O
110	O
AGap=14	O
4.1	O
28	O
0.6	O
Ca:	O
8.2	O
Mg:	O
1.5	O
ALT:	O
21	O
AP:	O
211	O
Tbili:	O
0.6	O
Alb:	O
AST:	O
___	O
LDH:	O
478	O
wbc	O
5.4	O
hgb	O
11.0	O
plt	O
122	O
___:	O
13.6	O
INR:	O
1.3	O
CXR	O
___	O
Heart	O
size	O
and	O
mediastinum	O
are	O
stable.	O
Tortuous	O
aorta	O
is	O
noted.	O
Bibasal	O
consolidations	O
appear	O
to	O
be	O
slightly	O
more	O
pronounced	O
than	O
on	O
the	O
prior	O
study	O
dating	O
conjunction	O
with	O
mild	O
perihilar	O
vascular	O
enlargement	O
might	O
represent	O
minimal	O
degree	O
of	O
pulmonary	O
edema.	O
For	O
pre	O
size	O
assessment	O
of	O
pulmonary	O
findings	O
in	O
addition	O
please	O
review	O
CT	O
chest	O
from	O
___bdomen	O
from	O
___	O
demonstrating	O
metastatic	O
involvement	O
at	O
least	O
of	O
the	O
right	O
lower	O
lung	O
OSH	O
RUQ	O
U/S;	O
multiple	O
liver	O
masses	O
background	O
parenchyma	O
suspicious	O
for	O
chronic	O
liver	O
disease.	O
GB	O
not	O
visualized.	O
No	O
intrahepatic	O
duct	O
dilatation,	O
CBD	O
7mm.	O
No	O
hydro.	O
No	O
ascites	O
OSH	O
Ab	O
CT:	O
multiple	O
liver	O
lesions	O
increased	O
in	O
size	O
and	O
number	O
(comparison	O
to	O
___.	O
4.2cm	O
lesion	O
in	O
R	O
lobe	O
liver	O
seg	O
5	O
prev	O
3.1cm,	O
GB	O
resected.	O
INtra/extrahepatic	O
ducts	O
normal.	O
L	O
lung	O
base	O
w/	O
pulmonary	O
nodule.	O
larger	O
nodule	O
R	O
lung	O
base.	O
new	O
from	O
prior	O
study.	O
Airspace	O
dz	O
at	O
R	O
lung	O
base	O
lymphangitiic	O
spread	O
vs	O
pneumonia.	O
10mm	O
nonobstructing	O
L	O
lower	O
pole	O
renal	O
stone,	O
no	O
bowel	O
abnormalities.	O
new	O
LN	O
in	O
retroperitoneum	O
13mm	O
w/in	O
R	O
periarotic	O
region,	O
enlarging	O
LN	O
11mm	O
anterior	O
IVC	O
suspicious	O
for	O
metastatic	O
dz.	O
Bones	O
nl	O
Kidneys	O
and	O
ureters	O
nl.	O
Brief	O
Hospital	O
Course:	O
Mr	O
___	O
is	O
a	O
___	O
yr	O
old	O
male	O
with	O
hx	O
of	O
COPD,	O
DM,	O
HTN,	O
HLD,	O
remote	O
seizure,	B-Seizures
cirrhosis	O
related	O
to	O
alcohol	O
and	O
steatosis,	O
and	O
recent	O
L	O
___	O
toe	O
amputation	O
for	O
osteomyelitis.	O
Has	O
been	O
undergoing	O
gammaknife	O
for	O
___	O
but	O
now	O
with	O
increasing	O
metastatic	O
disease,	O
admitted	O
with	O
worsening	O
RUQ	O
pain	O
likely	O
related	O
to	O
liver	O
tumor	O
burden.	O
#RUQ	O
Abdominal	O
pain	O
-	O
Review	O
of	O
OSH	O
CT	O
and	O
MRI	O
last	O
month	O
shows	O
significantly	O
increased	O
liver	O
tumor	O
burden.	O
Exam/labs	O
not	O
c/w	O
cholecystitis	O
or	O
kidney	O
stone.	O
Did	O
have	O
slight	O
Hgb	O
drop	O
from	O
12	O
on	O
___	O
to	O
10.6	O
on	O
admission	O
(prior	O
baseline	O
___	O
but	O
hgb	O
remained	O
stable	O
and	O
no	O
hemorrhage	O
noted	O
on	O
OSH	O
CT.	O
-	O
Patient	O
intially	O
required	O
few	O
doses	O
of	O
IV	O
morphine,	O
then	O
achieved	O
pain	O
control	O
with	O
oxycodone.	O
UA	O
with	O
few	O
WBC,	O
UCx	O
pending	O
and	O
asymptomatic	O
so	O
doubt	O
UTI	B-Urinary_tract_infection
-	O
message	O
sent	O
to	O
Dr	O
___	O
there	O
is	O
any	O
role	O
for	O
further	O
palliative	O
radiation	O
but	O
not	O
expedited	O
inpatient	O
as	O
pain	O
could	O
be	O
controlled	O
as	O
outpatient	O
and	O
tumor	O
burden	O
gradually	O
increasing	O
over	O
past	O
few	O
months	O
#RLL	O
infiltrate	O
-	O
Noted	O
on	O
OSH	O
CXR,	O
started	O
on	O
unasyn,	O
film	O
here	O
shows	O
increased	O
slight	O
bibasilar	O
consolidations	O
but	O
w/	O
evidence	O
of	O
R	O
base	O
metastatic	O
disease	O
on	O
CT.	O
No	O
systemic	O
signs	O
of	O
infection,	O
no	O
respiratory	O
symptoms,	O
pneumonia	B-Lower_respiratory_tract_infection
unlikely	O
thus	O
antibiotics	O
stopped	O
#HCC,	O
likely	O
metastatic	O
-	O
PET	O
last	O
month	O
now	O
with	O
uptake	O
in	O
lungs	O
(not	O
biopsy	O
proven)	O
as	O
well	O
as	O
worsened	O
liver	O
lesions.	O
Pt	O
has	O
upcoming	O
visit	O
next	O
week	O
in	O
___	O
clinic,	O
will	O
discuss	O
options	O
wtih	O
Dr	O
___	O
whether	O
is	O
candidate	O
for	O
sorafenib,	O
chemotherapy	O
trials	O
or	O
further	O
radiation.	O
#Nausea,	O
chronic	O
-	O
likely	O
___	O
above,	O
not	O
related	O
to	O
eating,	O
intermittent.	O
on	O
PPI,	O
cont	O
zofran	O
which	O
gives	O
relief	O
#DM	O
-	O
Glc	O
in	O
normal	O
range,	O
held	O
metformin	O
for	O
48	O
hrs	O
post	O
contrast	O
on	O
___	O
#COPD	O
-	O
STable,	O
on	O
monthly	O
xolair,	O
low	O
dose	O
prednisone	O
per	O
his	O
pulmonologist	O
Dr	O
___	O
advair	O
prn	O
albuterol	O
while	O
hospitalized.	O
Stabl	O
eon	O
RA	O
#HTN	O
-	O
BP	O
wnl,	O
cont	O
lisinopril,	O
amlodipine	O
#Hx	O
cirrhosis	O
-	O
well	O
compensated,	O
no	O
significant	O
ascites	O
on	O
recent	O
imaging	O
although	O
on	O
daily	O
lasix,	O
no	O
hyperbili,	O
encephalopathy,	O
varices.	O
Does	O
have	O
mild	O
and	O
gradually	O
worsening	O
thrombocytopenia	O
and	O
borderline	O
elevated	O
INR	O
but	O
may	O
be	O
nutritional	O
#Hypomagenesmia	O
-	O
___	O
decreased	O
PO	O
intake,	O
supplemented	O
w/	O
Mg	O
oxide	O
#Hypokalemia	O
-	O
___	O
decreased	O
PO	O
itnake	O
and	O
lasix	O
use,	O
supplemented	O
per	O
scale,	O
encouraged	O
high	O
potassium	O
foods	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
albuterol	O
sulfate	O
90	O
mcg/actuation	O
inhalation	O
q4	O
hr	O
prn	O
SOB,	O
wheezing	O
2.	O
Albuterol	O
Inhaler	O
___	O
PUFF	O
IH	O
QID	O
3.	O
Amlodipine	O
5	O
mg	O
PO	O
DAILY	O
4.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
5.	O
Atorvastatin	O
40	O
mg	O
PO	O
DAILY	O
6.	O
Calcium	O
Carbonate	O
500	O
mg	O
PO	O
DAILY	O
7.	O
Carbamazepine	O
200	O
mg	O
PO	O
BID	O
8.	O
Fluticasone	O
Propionate	O
NASAL	O
2	O
SPRY	O
NU	O
DAILY	O
9.	O
PredniSONE	O
10	O
mg	O
PO	O
DAILY	O
10.	O
Lisinopril	O
20	O
mg	O
PO	O
DAILY	O
11.	O
MetFORMIN	O
(Glucophage)	O
1000	O
mg	O
PO	O
BID	O
12.	O
Prochlorperazine	O
10	O
mg	O
PO	O
Q6H:PRN	O
nausea	O
13.	O
Lorazepam	O
0.5-1	O
mg	O
PO	O
Q6H:PRN	O
nausea,	O
anxiety	O
14.	O
Montelukast	O
10	O
mg	O
PO	O
DAILY	O
15.	O
omalizumab	O
150	O
mg	O
subcutaneous	O
monthly	O
16.	O
Omeprazole	O
20	O
mg	O
PO	O
BID	O
17.	O
Furosemide	O
20	O
mg	O
PO	O
DAILY	O
18.	O
Fluticasone-Salmeterol	O
Diskus	O
(250/50)	O
1	O
INH	O
IH	O
BID	O
Discharge	O
Medications:	O
1.	O
Albuterol	O
Inhaler	O
___	O
PUFF	O
IH	O
QID	O
2.	O
Amlodipine	O
5	O
mg	O
PO	O
DAILY	O
3.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
4.	O
Atorvastatin	O
40	O
mg	O
PO	O
DAILY	O
5.	O
Carbamazepine	O
200	O
mg	O
PO	O
BID	O
6.	O
Fluticasone	O
Propionate	O
NASAL	O
2	O
SPRY	O
NU	O
DAILY	O
7.	O
Fluticasone-Salmeterol	O
Diskus	O
(250/50)	O
1	O
INH	O
IH	O
BID	O
8.	O
Furosemide	O
20	O
mg	O
PO	O
DAILY	O
9.	O
Lisinopril	O
20	O
mg	O
PO	O
DAILY	O
10.	O
MetFORMIN	O
(Glucophage)	O
1000	O
mg	O
PO	O
BID	O
11.	O
Montelukast	O
10	O
mg	O
PO	O
DAILY	O
12.	O
Omeprazole	O
20	O
mg	O
PO	O
BID	O
13.	O
PredniSONE	O
10	O
mg	O
PO	O
DAILY	O
14.	O
Prochlorperazine	O
10	O
mg	O
PO	O
Q6H:PRN	O
nausea	O
15.	O
OxycoDONE	O
(Immediate	O
Release)	O
___	O
mg	O
PO	O
Q6H:PRN	O
breakthrough	O
pain	O
RX	O
*oxycodone	O
5	O
mg	O
___	O
tablet(s)	O
by	O
mouth	O
every	O
4	O
hours	O
as	O
needed	O
Disp	O
#*120	O
Tablet	O
Refills:*2	O
16.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID:PRN	O
constipation	O
RX	O
*docusate	O
sodium	O
100	O
mg	O
1	O
capsule(s)	O
by	O
mouth	O
twice	O
daily	O
as	O
needed	O
Disp	O
#*30	O
Capsule	O
Refills:*2	O
17.	O
albuterol	O
sulfate	O
90	O
mcg/actuation	O
INHALATION	O
Q4	O
HR	O
prn	O
SOB,	O
wheezing	O
18.	O
Calcium	O
Carbonate	O
500	O
mg	O
PO	O
DAILY	O
19.	O
Lorazepam	O
0.5-1	O
mg	O
PO	O
Q6H:PRN	O
nausea,	O
anxiety	O
20.	O
omalizumab	O
150	O
mg	O
subcutaneous	O
monthly	O
21.	O
Ondansetron	O
8	O
mg	O
PO	O
Q8H:PRN	O
nausea	O
RX	O
*ondansetron	O
8	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
every	O
8	O
hours	O
Disp	O
#*60	O
Tablet	O
Refills:*1	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
Hepatocellular	O
carcinoma	O
Abdominal	O
pain	O
Discharge	O
Condition:	O
Condition	O
-	O
stable	O
Mental	B-Delirium
status	B-Delirium
-	B-Delirium
Alert,	B-Delirium
coherent	B-Delirium
Ambulatory	B-Independently_mobile
status	B-Independently_mobile
-	B-Independently_mobile
independent	B-Independently_mobile
Discharge	O
Instructions:	O
Mr	O
___	O
it	O
was	O
a	O
pleasure	O
caring	O
for	O
you	O
during	O
your	O
stay	O
at	O
___.	O
You	O
were	O
hospitalized	O
with	O
worsening	O
pain	O
on	O
the	O
R	O
side	O
of	O
the	O
abdomen	O
and	O
on	O
exam	O
this	O
appears	O
to	O
be	O
over	O
the	O
liver.	O
The	O
CT	O
scan	O
done	O
at	O
___	O
shows	O
that	O
the	O
tumors	O
in	O
the	O
liver	O
have	O
grown	O
and	O
this	O
appears	O
to	O
be	O
the	O
source	O
of	O
the	O
pain.	O
It	O
did	O
improve	O
with	O
oxycodone.	O
Followup	O
Instructions:	O
___	O

